Literature DB >> 24909584

Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.

Nicolaas I Bohnen1, Kirk A Frey, Stephanie Studenski, Vikas Kotagal, Robert A Koeppe, Gregory M Constantine, Peter J H Scott, Roger L Albin, Martijn L T M Müller.   

Abstract

Cholinergic denervation has been associated with falls and slower gait speed and β-amyloid deposition with greater severity of axial motor impairments in Parkinson disease (PD). However, little is known about the association between the presence of extra-nigral pathological conditions and freezing of gait (FoG). Patients with PD (n = 143; age, 65.5 ± 7.4 years, Hoehn and Yahr stage, 2.4 ± 0.6; Montreal Cognitive Assessment score, 25.9 ± 2.6) underwent [(11) C]methyl-4-piperidinyl propionate acetylcholinesterase and [(11) C]dihydrotetrabenazine dopaminergic PET imaging, and clinical, including FoG, assessment in the dopaminergic "off" state. A subset of subjects (n = 61) underwent [(11) C]Pittsburgh compound-B β-amyloid positron emission tomography (PET) imaging. Normative data were used to dichotomize abnormal β-amyloid uptake or cholinergic deficits. Freezing of gait was present in 20 patients (14.0%). Freezers had longer duration of disease (P = 0.009), more severe motor disease (P < 0.0001), and lower striatal dopaminergic activity (P = 0.013) compared with non-freezers. Freezing of gait was more common in patients with diminished neocortical cholinergic innervation (23.9%, χ(2)  = 5.56, P = 0.018), but not in the thalamic cholinergic denervation group (17.4%, χ(2)  = 0.26, P = 0.61). Subgroup analysis showed higher frequency of FoG with increased neocortical β-amyloid deposition (30.4%, Fisher Exact test: P = 0.032). Frequency of FoG was lowest with absence of both pathological conditions (4.8%), intermediate in subjects with single extra-nigral pathological condition (14.3%), and highest with combined neocortical cholinopathy and amyloidopathy (41.7%; Cochran-Armitage trend test, Z = 2.63, P = 0.015). Within the group of freezers, 90% had at least one of the two extra-nigral pathological conditions studied. Extra-nigral pathological conditions, in particular the combined presence of cortical cholinopathy and amyloidopathy, are common in PD with FoG and may contribute to its pathophysiology.
© 2014 International Parkinson and Movement Disorder Society. © 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  PET; Parkinson's disease; acetylcholine; dopamine; gait freezing; β-amyloid

Mesh:

Substances:

Year:  2014        PMID: 24909584      PMCID: PMC4162130          DOI: 10.1002/mds.25929

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

1.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  Freezer or non-freezer: clinical assessment of freezing of gait.

Authors:  Anke H Snijders; Charlotte A Haaxma; Yolien J Hagen; Marten Munneke; Bastiaan R Bloem
Journal:  Parkinsonism Relat Disord       Date:  2011-10-02       Impact factor: 4.891

3.  Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease.

Authors:  James M Shine; Elie Matar; Philip B Ward; Samuel J Bolitho; Moran Gilat; Mark Pearson; Sharon L Naismith; Simon J G Lewis
Journal:  Brain       Date:  2013-03-12       Impact factor: 13.501

4.  Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.

Authors:  Myria Petrou; Nicolaas I Bohnen; Martijn L T M Müller; Robert A Koeppe; Roger L Albin; Kirk A Frey
Journal:  Neurology       Date:  2012-08-29       Impact factor: 9.910

5.  Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait.

Authors:  Brett W Fling; Rajal G Cohen; Martina Mancini; John G Nutt; Damian A Fair; Fay B Horak
Journal:  Brain       Date:  2013-07-03       Impact factor: 13.501

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.

Authors:  S Nagatsuka Si; K Fukushi; H Shinotoh; H Namba; M Iyo; N Tanaka; A Aotsuka; T Ota; S Tanada; T Irie
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

8.  Freezing of gait in Parkinson's disease is associated with functional decoupling between the cognitive control network and the basal ganglia.

Authors:  James M Shine; Elie Matar; Philip B Ward; Michael J Frank; Ahmed A Moustafa; Mark Pearson; Sharon L Naismith; Simon J G Lewis
Journal:  Brain       Date:  2013-10-18       Impact factor: 13.501

9.  Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Sid Gilman; Roger L Albin; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

10.  Frequent amyloid deposition without significant cognitive impairment among the elderly.

Authors:  Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk
Journal:  Arch Neurol       Date:  2008-11
View more
  49 in total

1.  Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease.

Authors:  Peter T Bell; Moran Gilat; Claire O'Callaghan; David A Copland; Michael J Frank; Simon J G Lewis; James M Shine
Journal:  Hum Brain Mapp       Date:  2014-11-25       Impact factor: 5.038

2.  Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.

Authors:  Richard Gordon; Neeraj Singh; Vivek Lawana; Anamitra Ghosh; Dilshan S Harischandra; Huajun Jin; Colleen Hogan; Souvarish Sarkar; Dharmin Rokad; Nikhil Panicker; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  Neurobiol Dis       Date:  2016-05-02       Impact factor: 5.996

Review 3.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

Review 4.  Freezing of gait: understanding the complexity of an enigmatic phenomenon.

Authors:  Daniel Weiss; Anna Schoellmann; Michael D Fox; Nicolaas I Bohnen; Stewart A Factor; Alice Nieuwboer; Mark Hallett; Simon J G Lewis
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

5.  Neurological update: emerging issues in gait disorders.

Authors:  Simon J G Lewis
Journal:  J Neurol       Date:  2015-03-04       Impact factor: 4.849

Review 6.  PET Imaging in Movement Disorders.

Authors:  Baijayanta Maiti; Joel S Perlmutter
Journal:  Semin Nucl Med       Date:  2018-08-16       Impact factor: 4.446

7.  Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses.

Authors:  Kamin Kim; Martijn L T M Müller; Nicolaas I Bohnen; Martin Sarter; Cindy Lustig
Journal:  Neuroimage       Date:  2017-02-05       Impact factor: 6.556

8.  Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss.

Authors:  Aaron Kucinski; Roger L Albin; Cindy Lustig; Martin Sarter
Journal:  Behav Brain Res       Date:  2015-01-14       Impact factor: 3.332

9.  Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.

Authors:  Neha Shah; Kirk A Frey; Martijn L T M Müller; Myria Petrou; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Roger L Albin; Nicolaas I Bohnen
Journal:  Mov Disord       Date:  2015-09-18       Impact factor: 10.338

10.  Short-latency afferent inhibition in patients with Parkinson's disease and freezing of gait.

Authors:  Marina Picillo; Raffaele Dubbioso; Rosa Iodice; Alessandro Iavarone; Chiara Pisciotta; Emanuele Spina; Lucio Santoro; Paolo Barone; Marianna Amboni; Fiore Manganelli
Journal:  J Neural Transm (Vienna)       Date:  2015-07-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.